title: Indirect induction of regulatory T cells accompanies immune responses during peptide vaccination of chronic lymphocytic leukaemia patients.
authors: Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.
authors: Katarzyna
authors: K
authors: Skorka
authors: Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.
authors: Joanna
authors: J
authors: Zaleska
authors: Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.
authors: Malgorzata
authors: M
authors: Zajac
authors: Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.
authors: Agnieszka
authors: A
authors: Karczmarczyk
authors: Department of Haematooncology and BMT Unit, Medical University of Lublin, Lublin, Poland.
authors: Waldemar
authors: W
authors: Tomczak
authors: Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.
authors: Paulina
authors: P
authors: Wlasiuk
authors: Department of Haematooncology and BMT Unit, Medical University of Lublin, Lublin, Poland.
authors: Malgorzata
authors: M
authors: Kowal
authors: Department of Internal Medicine III, Medical Clinic, University Clinic Ulm, University of Ulm, Ulm, Germany.
authors: Marlies
authors: M
authors: Goetz
authors: Department of Internal Medicine III, Medical Clinic, University Clinic Ulm, University of Ulm, Ulm, Germany.|Diakonie-Hospital Stuttgart, Stuttgart, Germany.
authors: Jochen
authors: J
authors: Greiner
authors: Medical Clinic V (Haematology/Oncology/Rheumatology), University Clinic Heidelberg, Heidelberg, Germany.
authors: Michael
authors: M
authors: Schmitt
authors: Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland. krzysztof.giannopoulos@gmail.com.|Department of Haematooncology and BMT Unit, Medical University of Lublin, Lublin, Poland. krzysztof.giannopoulos@gmail.com.
authors: Krzysztof
authors: K
authors: Giannopoulos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D019496:Cancer Vaccines; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007376:Interleukin-2 / Q000494:pharmacology; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D013792:Thalidomide / Q000494:pharmacology; D014611:Vaccination; D022223:Vaccines, Subunit
chemical_list: D019496:Cancer Vaccines; C508594:IL2 protein, human; D007376:Interleukin-2; D022223:Vaccines, Subunit; D013792:Thalidomide
keywords: T regulatory cells; chronic lymphocytic leukaemia; interleukin 2; peptide vaccination; thalidomide